Andrea K.
- Country
- Germany
- Department
- Innere Medizin A
Research Overview
- Early treatment intensification in patients with high risk Mantle Cell Lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with Rituximab and Ibrutinib and 6 months Ibrutinib maintenance (Arm A) as compared to standard of care induction and maintenance (Arm B)
- Phase III Study of Polatuzumab Vedotin with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Phase III Randomized Trial of De-escalated MATRix Induction Therapy in Newly Diagnosed Primary CNS Lymphoma: Methotrexate, Cytarabine, Thiotepa, and Rituximab
Data & Insights
Has run more than one trial at 60 of 228 partner sites.
Specializations
Lymphoma Treatment Innovation
The investigator specializes in advanced treatments for various forms of lymphoma, with particular focus on B-cell lymphomas and novel therapeutic approaches including CAR-T cell therapy and antibody-drug conjugates.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Mantle Cell Lymphoma (MCL)
- Primary CNS Lymphoma
Expertise extends to specialized interventions for elderly patients and those with aggressive disease presentations.
Advanced Therapeutic Strategies
Focus areas include the development and implementation of combination therapies utilizing innovative treatment approaches such as bispecific antibodies and targeted molecular agents.
- Stem Cell Transplantation
- Immunotherapy Combinations
- Novel Drug Development
Specializes in treatment strategies for both newly diagnosed and relapsed/refractory disease states.
Specialized Treatment Programs
Conducts research in targeted therapies for specific lymphoma subtypes, including rare variants and challenging clinical presentations.
- Waldenström's Macroglobulinemia
- Hodgkin Lymphoma
- Follicular Lymphoma
Develops personalized treatment approaches based on patient-specific factors and disease characteristics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.